Signs of fluid and electrolyte problems like mood changes, confusion, muscle pain or weakness, a heartbeat that does not feel normal, very bad dizziness or passing out, fast heartbeat, more thirst, seizures, feeling very tired or weak, not hungry, unable to pass urine or change in the amount of urine produced, dry mouth, dry eyes, or very bad upset stomach or throwing up
Additionally, it synergistically interacts with resistance exercise to enhance MPS, maintain skeletal muscle mass, increase type II fiber size, elevate strength and functional performance, and mitigate the risk of frailty
Variants in GLP1R (the GLP-1 receptor itself), GIPR (the GIP receptor relevant to tirzepatide's dual mechanism), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with measurably different response patterns to semaglutide and tirzepatide
However, some clinicians prefer a more conservative approach even from high tirzepatide doses, starting semaglutide at 0.5 mg and titrating up every 4 weeks
Giorgino F, Benroubi M, Sun JH, Zimmermann AG, Pechtner V
